Consilium Strategic Communications and Covington & Burling LLP to Host 2014 Annual Healthcare Conference "The Future of Healthcare - Funding Options, Innovation and M&A for 2015 and Beyond"
LONDON, November 17, 2014 /PRNewswire/ --
Consilium Strategic Communications, a global leader in healthcare financial public and investor relations, will host its Annual Healthcare Conference in collaboration with Covington & Burling LLP on Tuesday, 18 November 2014. The conference will explore "The Future of Healthcare - funding options, innovation and M&A for 2015 and beyond" and will take place at the London Stock Exchange.
This invitation-only event will bring together panel speakers from the global healthcare sector, government and investment community, to discuss topical themes and trends across the industry. Encouraging debates on topics including the decision of companies to "Go West" for investment and to consider public listings in the US versus Europe as well as questioning whether or not M&A really does create value or reduce costs, the conference is well attended by European healthcare companies across all sub-sectors, Board members, the investment community and business development representatives.
Mary-Jane Elliott, Managing Partner and co-founder of Consilium Strategic Communications, commented: "Gathering our clients and contacts for networking and information sharing is key to our advisory offering. Our annual Healthcare Conference has gained great momentum and continues to attract international leaders in healthcare from industry, the investment community, journalism and banking. We are looking forward to the lively debates which we are sure will ensue amongst our notable speakers."
Simon Amies, partner in the London office of Covington & Burling LLP, comments: "We are delighted once again to be hosting this leading healthcare conference alongside Consilium Strategic Communications. The healthcare sector is responding to numerous challenges, but at the same time creating new opportunities, by adopting new business strategies, including the development of novel funding and collaboration models, and creative partnering with the technology sector. The conference promises valuable insights on these topics from industry experts, successful entrepreneurs and leading commentators."
Panel Topics
1. Novel funding mechanics
VCs, specialist and generalist investors and an IP commercialisation group will discuss novel funding mechanics for 2015. The panel will be joined by the CEO of a successful international family owned business.
Panel speakers:
Geraldine O'Keeffe - LSP, Partner (Panel Chair)
James Noble - Adaptimmune, Chief Executive Officer
Riccardo Braglia - Helsinn Group, Chief Executive Officer and Managing Director
David Solomon - Zealand Pharma, President & Chief Executive Officer
2. Go West? Attractiveness of US capital markets
Europeans look to list in the US and tap into a broader investor base and enhanced valuations. This panel will include companies that have already made that journey and the bankers and investors involved.
Panel speakers:
Kristian Wiggert - Covington & Burling LLP, Partner (Panel Chair)
Edwin Moses - Ablynx, Chief Executive Officer
Justin Gover - GW Pharma, Chief Executive Officer
Catherine Moukheibir - Innate Pharma, Executive
3.Big Data - the future of healthcare?
Data generated by consumers and captured by modern technologies is giving invaluable insight into how patients are using products and their effectiveness. This panel will explore the commercial opportunities that await for those that can harness, parse and analyse this data, and leverage it to inform strategy decisions, spur innovation, inspire new products, enhance customer relationships, and bolster operations.
Panel speakers:
Ken Noonan - LEK, Senior Advisor
Lord Drayson
Povl Verder - SIME Diagnostics, Chief Executive Officer
4. Capturing value in innovation
As realisation dawns on value lost historically by not protecting and locking down IP, entrepreneurs, institutions and specialist advisors will speak out in this panel about the importance of enhancing IP creation and development.
Panel speakers:
Peter Keen - Cambridge Innovation Capital, Chief Executive Officer (Panel Chair)
David Baynes - IP Group, Chief Operating Officer
Kit Malthouse - Deputy Mayor for Business and Enterprise
Katya Smiryagina - Capricorn, Partner
5. An interview on Big pharma - "Does M&A create value or reduce costs?"
An interview with Andrew Ward, Pharmaceutical Correspondent at the Financial Times, and Francois Maisonrouge, Senior Managing Director at Evercore Partners.
For a detailed agenda, please visit http://www.consilium-comms.com/news-and-events
About Consilium Strategic Communications
Consilium Strategic Communications is a global leader in strategic healthcare communications advisory with offices in London, New York and Singapore. Consilium's highly-skilled team provides strategic, long-term advice to healthcare companies, Boards, senior decision makers and executives on critical communications programmes and stakeholder challenges. The Company has established deep knowledge across all areas of the global healthcare sector through broad experience in representing international clients spanning the Fortune 500, FTSE100, FTSEurofirst 300 and FTSE250, through to discrete specialist reputation management projects.
About Covington & Burling
In an increasingly regulated world, Covington & Burling LLP provides corporate, litigation, and regulatory expertise to help clients navigate through their most complex business problems, deals and disputes. Founded in 1919, the firm has more than 800 lawyers in offices in Beijing, Brussels, London, New York, San Diego, San Francisco, Seoul, Shanghai, Silicon Valley, and Washington.
For more information please contact:
Consilium Strategic Communications
Mary-Jane Elliott / Amber Bielecka / Emma Thompson
Tel: +44(0)20-3709-5702 / +65-9171-2862
[email protected]
http://www.consilium-comms.com
Follow us: @consiliumhc
SOURCE Consilium Strategic Communications
Share this article